VERU INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
VERU INC. (VERU) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$7.83 million for the 12-month period ending 2017-09-30, per its 10-K filed 2018-01-02.
Discontinued › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2018-01-02
- VERU INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2017 was -$7.83M, a 833.09% decline from fiscal 2016.
- VERU INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2016 was $1.07M, a 76.38% decline from fiscal 2015.
- VERU INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2015 was $4.52M, a 59.43% increase from fiscal 2014.
- VERU INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2014 was $2.84M, a 61.97% decline from fiscal 2013.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2017-09-30 | -$7.83M 10-K · filed 2018-01-02 |
| 2016-09-30 | $1.07M 10-K · filed 2018-01-02 |
| 2015-09-30 | $4.52M 10-K · filed 2018-01-02 |
| 2014-09-30 | $2.84M 10-K · filed 2016-12-12 |
| 2013-09-30 | $7.46M 10-K · filed 2015-12-02 |
| 2012-09-30 | $6.29M 10-K · filed 2014-12-02 |
| 2011-09-30 | $1.64M 10-K · filed 2013-12-03 |
| 2010-09-30 | $2.68M 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |